C
Christopher M. Clark
Researcher at Eli Lilly and Company
Publications - 1
Citations - 321
Christopher M. Clark is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Randomized controlled trial & Cognitive decline. The author has an hindex of 1, co-authored 1 publications receiving 280 citations.
Papers
More filters
Journal ArticleDOI
Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures
Douglas Galasko,Elaine R. Peskind,Christopher M. Clark,Joseph F. Quinn,John M. Ringman,Gregory A. Jicha,Carl W. Cotman,Barbara A. Cottrell,Thomas J. Montine,Ronald G. Thomas,Paul S. Aisen +10 more
TL;DR: Antioxidants did not influence CSF biomarkers related to amyloid or tau pathology, and lowering of CSF F2-isoprostane levels in the E/C/ALA group suggests reduction of oxidative stress in the brain.